Early bird registration is open and closes May 2025. Register now
Abstracts deadline Friday 24 April 2026! Submit now
Celltrion is a leading global biopharmaceutical company dedicated to improving the health and well-being of patients.
We have presented a new paradigm to the global biologics market with the launch of the world’s first monoclonal antibody biosimilar.
Celltrion will continue to pursue its goal in promoting the health and well-being of patients.
Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.
Have you registered yet? Don't miss your chance on attending live sessions featuring the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.
